Leap Therapeutics
LPTX
LPTX
41 hedge funds and large institutions have $49.2M invested in Leap Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.06M | |
| 2 | +$1.01M | |
| 3 | +$833K | |
| 4 |
Two Sigma Investments
New York
|
+$614K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$440K |
Top Sellers
| 1 | -$2.74M | |
| 2 | -$1.88M | |
| 3 | -$1.47M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$1.21M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$1.04M |